Skip to main content
An official website of the United States government

yttrium Y 90 monoclonal antibody BrE-3

A radioimmunotherapeutic agent consisting of a monoclonal antibody (BrE-3) directed against the tumor-associated antigen epithelial glycoprotein mucin chelated to the radioisotope yttrium-90. Yttrium Y 90 monoclonal antibody BrE-3 binds to tumor cells expressing epithelial glycoprotein mucin, selectively delivering a cytotoxic dose of beta radiation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:MOAB BrE-3, yttrium Y 90
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search